Why has NICE said this?
Pixantrone was recommended because it is an effective treatment for people with non-Hodgkin's B‑cell lymphoma. Although it costs more than other treatments, this was justified by the benefits it provided.
NICE looks at how well treatments work in relation to how much they cost compared with other treatments available on the NHS.